Correlation Between CSPC PHARMACEUTGR and Bayer Aktiengesellscha

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CSPC PHARMACEUTGR and Bayer Aktiengesellscha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSPC PHARMACEUTGR and Bayer Aktiengesellscha into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSPC PHARMACEUTGR ADR4 and Bayer Aktiengesellschaft, you can compare the effects of market volatilities on CSPC PHARMACEUTGR and Bayer Aktiengesellscha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSPC PHARMACEUTGR with a short position of Bayer Aktiengesellscha. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSPC PHARMACEUTGR and Bayer Aktiengesellscha.

Diversification Opportunities for CSPC PHARMACEUTGR and Bayer Aktiengesellscha

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between CSPC and Bayer is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding CSPC PHARMACEUTGR ADR4 and Bayer Aktiengesellschaft in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bayer Aktiengesellschaft and CSPC PHARMACEUTGR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSPC PHARMACEUTGR ADR4 are associated (or correlated) with Bayer Aktiengesellscha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bayer Aktiengesellschaft has no effect on the direction of CSPC PHARMACEUTGR i.e., CSPC PHARMACEUTGR and Bayer Aktiengesellscha go up and down completely randomly.

Pair Corralation between CSPC PHARMACEUTGR and Bayer Aktiengesellscha

Assuming the 90 days trading horizon CSPC PHARMACEUTGR ADR4 is expected to generate 0.92 times more return on investment than Bayer Aktiengesellscha. However, CSPC PHARMACEUTGR ADR4 is 1.09 times less risky than Bayer Aktiengesellscha. It trades about -0.01 of its potential returns per unit of risk. Bayer Aktiengesellschaft is currently generating about -0.03 per unit of risk. If you would invest  295.00  in CSPC PHARMACEUTGR ADR4 on August 29, 2024 and sell it today you would lose (69.00) from holding CSPC PHARMACEUTGR ADR4 or give up 23.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

CSPC PHARMACEUTGR ADR4  vs.  Bayer Aktiengesellschaft

 Performance 
       Timeline  
CSPC PHARMACEUTGR ADR4 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CSPC PHARMACEUTGR ADR4 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, CSPC PHARMACEUTGR reported solid returns over the last few months and may actually be approaching a breakup point.
Bayer Aktiengesellschaft 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bayer Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

CSPC PHARMACEUTGR and Bayer Aktiengesellscha Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CSPC PHARMACEUTGR and Bayer Aktiengesellscha

The main advantage of trading using opposite CSPC PHARMACEUTGR and Bayer Aktiengesellscha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSPC PHARMACEUTGR position performs unexpectedly, Bayer Aktiengesellscha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bayer Aktiengesellscha will offset losses from the drop in Bayer Aktiengesellscha's long position.
The idea behind CSPC PHARMACEUTGR ADR4 and Bayer Aktiengesellschaft pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity